Skip to content

13F-HR filed by Palo Alto Investors LP

Palo Alto Investors LP filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 32 holding rows worth $847,287,000.

Accession
0001140361-13-032185
Filed
2013-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 32 entries on the cover page, a total value of $847,287,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $847,287,000 with VALUE read as thousands by filing date, 13F file number 028-11013. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ONYX PHARMACEUTICALS INC683399109COM1,325,115$115,046,000thousands by filing date
VIROPHARMA INC928241108COMMON STOCK3,968,818$113,707,000thousands by filing date
CYBERONICS23251P102COMMON STOCK1,863,118$96,808,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock900,778$59,289,000thousands by filing date
ABIOMED INC003654100COM2,319,398$50,006,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK2,847,842$47,362,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM787,119$43,874,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM1,680,871$37,399,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM756,821$36,547,000thousands by filing date
SEQUENOM INC COM NEW817337405COM8,202,692$34,533,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock3,211,318$32,595,000thousands by filing date
QUESTCOR PHARMACEUTICALS INC74835Y101COM696,297$31,640,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM2,381,876$19,246,000thousands by filing date
ALIMERA SCIENCES INC016259103COM3,634,984$17,739,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM1,175,076$17,697,000thousands by filing date
INTERMUNE INC45884X103COM1,775,485$17,080,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK3,935,576$13,145,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM4,622,230$10,770,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM1,617,651$9,043,000thousands by filing date
AVEO PHARMACEUTICALS INC053588109COM3,509,205$8,773,000thousands by filing date
QLT INC746927102COMMON STOCK1,950,636$8,563,000thousands by filing date
SAVIENT PHARMACEUTICALS INC80517Q100COM9,744,833$5,457,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock266,299$3,185,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM49,040$3,106,000thousands by filing date
CYTOKINETICS INC23282W100CMN261,544$3,026,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM395,985$2,954,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM86,201$2,332,000thousands by filing date
XOMA CORP DEL98419J107COM522,683$1,897,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM83,600$1,839,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock88,500$1,143,000thousands by filing date
DENDREON CORP24823Q107COM207,800$856,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK44,129$630,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-13-032185this filing2013-08-14acceptance time not in the bulk data set